Berman Capital Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$43K Buy
901
+1
+0.1% +$51 0.01% 734
2021
Q2
$47K Buy
900
+22
+3% +$1.15K 0.01% 616
2021
Q1
$43K Buy
878
+25
+3% +$1.2K 0.01% 534
2020
Q4
$41K Buy
853
+25
+3% +$1.23K 0.01% 460
2020
Q3
$41K Sell
828
-74
-8% -$3.81K 0.01% 400
2020
Q2
$45K Buy
902
+246
+38% +$12K 0.01% 347
2020
Q1
$28K Buy
656
+51
+8% +$2.44K 0.01% 417
2019
Q4
$30K Hold
605
0.01% 434
2019
Q3
$28K Hold
605
0.01% 420
2019
Q2
$26K Buy
605
+161
+36% +$6.85K 0.01% 443
2019
Q1
$19K Sell
444
-590
-57% -$25.3K 0.01% 474
2018
Q4
$44K Buy
+1,034
New +$45.6K 0.02% 264

Other funds holding SNY

Berman Capital Advisors's SNY Position: Q3 2021 in Review

Berman Capital Advisors increased its Sanofi (SNY) stake by 0.11% in Q3 2021, buying an estimated $51 and bringing the position to 901 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #734.

Berman Capital Advisors first reported a position in SNY in Q4 2018 and has held it in 12 quarters since. The position peaked at $47K in Q2 2021. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

  • Berman Capital Advisors held 901 shares of Sanofi worth $43K as of Q3 2021.
  • Berman Capital Advisors bought 1 Sanofi share in Q3 2021, an estimated $51.
  • Sanofi made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #734 holding.
  • Berman Capital Advisors first reported a position in Sanofi in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's Sanofi position peaked at $47K in Q2 2021.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.